BioMed X Ukraine Refugee Funding Program

BioMed X joins international efforts to offer a new scientific home to Ukraine refugee scientists

BioMed X and some of its partners offer Ukrainian doctoral students and master-level researchers in the life sciences the opportunity to continue their work in a research group at the BioMed X Institute in Heidelberg, Germany.

Russia’s Ukraine Attack and the Impact on Science

Since Russia’s attack on Ukraine started on February 24, scientists face unbelievable challenges in continuing their work. While some scientists and students are still in Ukraine, many of them are among the more than 5 million refugees who left the country.

Scientists and institutions around the world have responded by offering work to displaced scientists from Ukraine. The BioMed X Institute and some of its partners have decided to join this international effort to help the Ukrainian scientific community.

“The situation in Ukraine is a tragedy which requires a joint effort to offer support and help. The BioMed X Institute is a place where early-career scientists are given the opportunity to develop themselves. Together with some of our partners we launched this funding program because we sincerely hope to provide a scientific home for some of the researchers who cannot continue their career in Ukraine.

Thomas Rückle
Senior Vice President and Head of Research at the BioMed X Institute

Eligibility for the Ukraine Refugee Funding Program

  • Eligible for this funding program are early-career scientists that are unable to continue their research projects because of the war in Ukraine, regardless of their nationality. An early-career scientist is either a doctoral student or a master-level researcher.
  • Ideal candidates have a master’s degree, as well as research experience, in either molecular/cell biology, bio-organic chemistry, pharmacology or physics.
  • German language knowledge is not required.

Research at BioMed X Institute

The work at BioMed X is focused on biomedical research that will enable the design of new targeted therapies. Current active BioMed X projects investigate different aspects of autoimmunity and neurological disorders or aim to develop novel cancer treatments. Working on a BioMed X project entails deciphering a fundamental research question, while also integrating the data into a pipeline that will lead to an application. Having had the experience of an industry-advised project, at the end of their project, scientists at BioMed X easily find new career opportunities both in academia and in the industry.

Learn more about our research groups

Life as a Scientist in Heidelberg

Heidelberg is a city in the south-west of Germany, approximately one hour away from Frankfurt am Main. Despite being a relatively small city (160,000 inhabitants), it is highly cosmopolitan, with a rich history and a dynamic science community. In fact, Heidelberg is one of the largest biomedical research hubs in Europe and home to world-renowned research institutes, such as the German Cancer Research Center (DKFZ) and the European Molecular Biology Laboratory (EMBL).

Learn more about work at BioMed X and life in Heidelberg

Need more information on the Ukraine Refugee Funding Program?

For any questions, please contact Dr. Thomas Rückle.

Dr. Thomas Rückle

Senior Vice President Research